SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014)
SELLAS Life Sciences (SLS) reported Capital Leases of $17000.0 for Q3 2014, down 43.33% year-over-year from $30000.0 in Q3 2013, and down 10.53% on a QoQ basis from $19000.0 in Q2 2014.
SELLAS Life Sciences (SLS) has 5 years of Capital Leases data on file, last reported at $17000.0 in Q3 2014.
- Quarterly Capital Leases fell 43.33% year-over-year to $17000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $17000.0 (down 43.33% YoY) and the FY2013 annual result came in at $26000.0, down 49.02% from the prior year.
- Capital Leases fell to $17000.0 in Q3 2014 per SLS's latest filing, from $19000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $51000.0 in Q3 2012 and bottomed at $10000.0 in Q2 2011.
- The 5-year median for Capital Leases is $28000.0 (2013), against an average of $29571.4.
- The widest annual swing landed in 2012, when Capital Leases soared 264.29%; it then sank 54.9% in 2014.
- Tracing SLS's Capital Leases over 5 years: stood at $20000.0 in 2010, then soared by 60.0% to $32000.0 in 2011, then jumped by 59.38% to $51000.0 in 2012, then tumbled by 49.02% to $26000.0 in 2013, then plunged by 34.62% to $17000.0 in 2014.
- Per Business Quant, the three latest SLS Capital Leases figures stand at $17000.0 (Q3 2014), $19000.0 (Q2 2014), and $23000.0 (Q1 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 26,000.00 |
| Sep 30, 2013 | 30,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Mar 31, 2013 | 51,000.00 |
| Dec 31, 2012 | 51,000.00 |
| Sep 30, 2012 | 51,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 32,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 20,000.00 |